Risk stratification by circulating tumor DNA-based pretreatment genomic profile and post-operative molecular residual disease detection in resectable colorectal oligometastases: PRECISION, a prospective multicenter study
Blood-based tumor markers before surgery and afterward independently predicted recurrence risk in colorectal cancer patients, helping guide follow-up decisions.
This prospective multicenter biomarker cohort study examined Risk stratification by circulating tumor DNA-based pretreatment genomic profile and post-operative molecular residual disease detection in resectable colorectal oligometastases: PRECISION, a prospective multicenter study. Poor pretreatment genomic profiles and postoperative molecular residual disease independently predicted shorter recurrence-free survival and time to surgical failure.
What the study was
- Study design
- Prospective multicenter biomarker cohort study
- Population
- Patients with previously untreated resectable colorectal oligometastases
- Sample size
- 118 eligible patients
- Category
- Genomics/Precision Medicine
- Maturity
- Exploratory
- Journal
- ESMO open
Why it surfaced
Prospective multicenter biomarker cohort study; Poor pretreatment genomic profiles and postoperative molecular residual disease independently predicted shorter recurrence-free survival and time to surgical failure. Score kept conservative because only the PubMed abstract and metadata were reviewed.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.